The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as

• transformation of antigen specific B lymphocytes (EBV)
• hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes
• combination of EB Vand hybridoma techniques
• all of these